# PT-141 (bremelanotide) and alcohol: phase I safety study

Source: https://pepvault.app/research/pt-141-clayton-2017

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [PT-141](https://pepvault.app/research#pt-141)

Randomized trial · people

# PT-141 with alcohol was well tolerated in 24 healthy adults

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In this early safety study, single doses of bremelanotide taken with alcohol did not add safety problems or change how the body handled either one in healthy adults.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 24
- **Published:** 2017
- **Journal:** Clin Ther

## What they tested

The team tested whether bremelanotide is safe and tolerable when taken together with alcohol, and whether alcohol changes how the body handles the drug.

## How the study was done

A randomized, placebo-controlled, double-blind crossover trial (each person got several treatment combinations in turn) in 24 healthy adults, 12 men and 12 women, over 7 days at a research site. On days 1, 4 and 7 they got a single 20 mg nasal dose of bremelanotide or placebo (a dummy dose), with or without 0.6 g/kg of alcohol by mouth, while fasting.

<!--promo-->

PepVault for iPhone

## Taking PT-141? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

All 24 people finished the study. The 20 mg nasal doses were judged safe and mostly well tolerated, with or without alcohol, and women reached average peak blood alcohol levels above 80 mg/dL. The team found no clinically significant pharmacokinetic interaction (no meaningful change in how the body handles either substance), overall or by sex, and no significant drug-related drops in blood pressure, including on standing. Bremelanotide did not raise the rate of side effects, no one dropped out because of side effects, and physical exams, ECGs (heart tracings) and lab tests showed no clinically significant changes.

## What it doesn’t show

This was a small, short study of single doses in healthy volunteers, so it does not show what happens with repeated use or in people with health problems. It tested a nasal form, which the team said gives exposure about 1 to 2 times that of the injected dose being studied in phase III trials.

## The paper

Clayton et al. Phase I Randomized Placebo-controlled, Double-blind Study of the Safety and Tolerability of Bremelanotide Coadministered With Ethanol in Healthy Male and Female Participants. Clin Ther. 2017.

- [PubMed (PMID 28189361)](https://pubmed.ncbi.nlm.nih.gov/28189361/)
- [The paper (DOI 10.1016/j.clinthera.2017.01.018)](https://doi.org/10.1016/j.clinthera.2017.01.018)
- [ClinicalTrials.gov (NCT02338960)](https://clinicaltrials.gov/study/NCT02338960)

## The compound

- [PT-141: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/pt-141)
- [PT-141 dose guide](https://pepvault.app/lab/dosage/pt-141)

## With this study

### PT-141

- [PT-141: the full reference](https://pepvault.app/peptides/pt-141)
- [PT-141 dose guide](https://pepvault.app/lab/dosage/pt-141)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/pt-141-10mg)

### Studies

- [PT-141: side-effect dropouts far higher than placebo in re-analysis](https://pepvault.app/research/pt-141-spielmans-2021)
- [PT-141: desire gains over placebo held across RECONNECT subgroups](https://pepvault.app/research/pt-141-reconnect-2022)
- [PT-141: more responders than placebo at 1.75 mg on all 7 measures](https://pepvault.app/research/pt-141-althof-2019)
- [All 6 studies](https://pepvault.app/research#pt-141)

### Compared with

- [PT-141 vs Melanotan II](https://pepvault.app/peptides/compare/pt-141-vs-melanotan-ii)
- [PT-141 vs Oxytocin](https://pepvault.app/peptides/compare/pt-141-vs-oxytocin)
- [PT-141 vs Setmelanotide](https://pepvault.app/peptides/compare/pt-141-vs-setmelanotide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)
- [Crossover trial](https://pepvault.app/glossary/crossover-trial)

## More studies on PT-141

- [PT-141: side-effect dropouts far higher than placebo in re-analysis](https://pepvault.app/research/pt-141-spielmans-2021) Meta-analysis · people · 2021
- [PT-141: desire gains over placebo held across RECONNECT subgroups](https://pepvault.app/research/pt-141-reconnect-2022) Randomized trial · people · 2022
- [PT-141: more responders than placebo at 1.75 mg on all 7 measures](https://pepvault.app/research/pt-141-althof-2019) Randomized trial · people · 2019
- [PT-141: +0.7 vs +0.2 satisfying sexual events a month at 12 weeks](https://pepvault.app/research/pt-141-clayton-2016) Randomized trial · people · 2016
- [PT-141: nausea in 40.0% vs 1.3% on placebo in phase 3 safety data](https://pepvault.app/research/pt-141-clayton-2022) Systematic review · people · 2022
- [Every study on PT-141](https://pepvault.app/research#pt-141)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking PT-141? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking PT-141? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### PT-141

- [PT-141: the full reference](https://pepvault.app/peptides/pt-141)
- [PT-141 dose guide](https://pepvault.app/lab/dosage/pt-141)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/pt-141-10mg)

### Studies

- [PT-141: side-effect dropouts far higher than placebo in re-analysis](https://pepvault.app/research/pt-141-spielmans-2021)
- [PT-141: desire gains over placebo held across RECONNECT subgroups](https://pepvault.app/research/pt-141-reconnect-2022)
- [PT-141: more responders than placebo at 1.75 mg on all 7 measures](https://pepvault.app/research/pt-141-althof-2019)
- [All 6 studies](https://pepvault.app/research#pt-141)

### Compared with

- [PT-141 vs Melanotan II](https://pepvault.app/peptides/compare/pt-141-vs-melanotan-ii)
- [PT-141 vs Oxytocin](https://pepvault.app/peptides/compare/pt-141-vs-oxytocin)
- [PT-141 vs Setmelanotide](https://pepvault.app/peptides/compare/pt-141-vs-setmelanotide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)
- [Crossover trial](https://pepvault.app/glossary/crossover-trial)

<!--promo-->

PepVault for iPhone

## Taking PT-141? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on PT-141](https://pepvault.app/research#pt-141)

## The library

- [PT-141](https://pepvault.app/peptides/pt-141)
- [PT-141 dose guide](https://pepvault.app/lab/dosage/pt-141)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
